Image by: Sean Pavone | Credit: Getty Images/iStock Photo
Meeting Objectives:
-
-
Examine the primary role of GLP-1 receptor agonists in improving glycemic control, with an emphasis on A1c reduction, glucose variability, and delaying disease progression in patients with Type 2 diabetes.
-
Review evidence from key clinical trials and real-world studies supporting the use of GLP-1 receptor agonists for holistic diabetes care, including glycemic control, weight management, reduced insulin dependence, and effectiveness across diverse patient populations.
-
Examine the cardiovascular and renal protective effects of GLP-1 receptor agonists while addressing practical considerations for implementation, including patient selection, adherence, and access challenges.
-
Share This Event